Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 942-947

  Abitbol, Andre ^a,b   Abdel Wahab, May ^b,c,d   Lewin, Alan ^a,b   Troner, Michael ^a   Rodrigues, Maria Amelia ^a   Hamilton Nelson, Kara L ^e   Markoe, Arnold ^b  

^a BAPTIST HOSPITAL OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CAIRO UNIVERSITY   (Egypt)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

Chemotherapy; Head and neck cancer; Hyperfractionated radiation

Indexed keywords

CELLS; PATIENT TREATMENT; TOXICITY;

ESOPHAGEAL STRICTURES;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; BONE NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG TOLERANCE; ESOPHAGUS STRICTURE; FEMALE; FEVER; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HYPOTHYROIDISM; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; PARESTHESIA; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037100035     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02816-X     Document Type: Article

References (33)

1. Induction chemotherapy plus radiation in patients with advanced laryngeal cancer
2. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial
3. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
4. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
5. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
6. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
7. A phase III comparison of standard radiation therapy (RT) vs RT plus concurrent cisplatin (DDP) vs split-course RT plus concurrent DDP and 5- fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): An Intergroup study
8. Meta-analysis of chemotherapy in head and neck squamous cell carcinoma on behalf of the MACH-NC collaborative group
9. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials
10. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer
11. Adjuvant chemotherapy for head and neck cancer
12. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
13. Simultaneous chemoradiation in the treatment of advanced head and neck cancer
14. Conventional versus accelerated fractionation in head and neck cancer
15. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin C in head and neck carcinoma: A pilot study
16. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin, mitomycin C (+/- G-CSF) for locally advanced head and neck carcinoma
17. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group Randomized Trial
18. Nonparametric estimation from incomplete observations
19. Continuous infusion paclitaxel, 5- fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer
20. Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: A phase I study
21. Sequences of Taxol and cisplatin: A phase I and pharmacologic study
22. Concomitant infusion paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer
23. Oropharyngeal carcinoma treated with radiotherapy: A 30 year experience
24. A multivariate primary tumor control analysis in 465 patients treated with radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors
25. External beam irradiation alone or combined with neck dissection for base of tongue carcinoma: An alternate to primary surgery
26. Carcinoma of the tonsillar fossa: A nonrandomized comparison of irradiation alone or combined with surgery - Long-term results
27. Squamous cell carcinoma of the base of tongue
28. Preoperative irradiation and surgery for carcinoma of the base of tongue
29. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
30. Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III, and IV oropharynx carcinoma: Results of the 94-01 randomized study from the French Group of Radiation Oncology for Head and Neck Cancer (GORTEC)
31. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy